Cerevel Therapeutics Holdings Inc Stock Ownership - Who owns Cerevel Therapeutics Holdings?

Insider buying vs selling

Have Cerevel Therapeutics Holdings Inc insiders been buying or selling?
N. Anthony ColesDirector2024-07-0125,000$3.50
N. Anthony ColesDirector2024-07-0125,000$41.18
N. Anthony ColesDirector2024-06-0350,000$40.61
N. Anthony ColesDirector2024-06-0350,000$3.50
N. Anthony ColesDirector2024-05-1050,000$42.10
N. Anthony ColesDirector2024-05-1050,000$3.50
N. Anthony ColesDirector2024-04-0150,000$3.50
N. Anthony ColesDirector2024-04-0150,000$42.33
N. Anthony ColesDirector2024-03-0450,000$41.01
N. Anthony ColesDirector2024-03-0450,000$3.50

1 of 6

CERE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CERE insiders and whales buy or sell their stock.

CERE Shareholders

What type of owners hold Cerevel Therapeutics Holdings Inc stock?
Adam Koppel69.34%126,325,880$5.40BInsider
Christopher R. Gordon69.34%126,325,880$5.40BInsider
Bain Capital Investors LLC69.33%126,312,137$5.40BInsider
Bain Capital Investors LLC36.05%65,679,781$2.81BInstitution
Pfizer Inc14.35%26,149,211$1.12BInsider
Perceptive Advisors LLC5.92%10,794,876$461.16MInsider
Perceptive Advisors LLC5.92%10,794,876$461.16MInstitution
Avoro Capital Advisors LLC4.15%7,555,555$322.77MInstitution
Vanguard Group Inc4.10%7,463,911$318.86MInstitution
Blackrock Inc2.99%5,448,620$232.77MInstitution

1 of 3

CERE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CERE26.70%73.30%Net BuyingNet Buying
RVMD89.67%10.33%Net SellingNet Selling
ROIV39.48%60.52%Net SellingNet Selling
BPMC81.88%18.12%Net SellingNet Selling

Cerevel Therapeutics Holdings Stock Ownership FAQ

Who owns Cerevel Therapeutics Holdings?

Cerevel Therapeutics Holdings (NASDAQ: CERE) is owned by 83.65% institutional shareholders, 229.68% Cerevel Therapeutics Holdings insiders, and 0.00% retail investors. Adam Koppel is the largest individual Cerevel Therapeutics Holdings shareholder, owning 126.33M shares representing 69.34% of the company. Adam Koppel's Cerevel Therapeutics Holdings shares are currently valued at $5.39B.

If you're new to stock investing, here's how to buy Cerevel Therapeutics Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.